Concepedia

Kun Zhu

KZ

Statistics

Publications

46

Citations

1.3K

H-Index

19

Active since

2005

Affiliations

First Affiliated Hospital of Xi'an Jiaotong University(Current)

Xi'an Jiaotong University

Children's Hospital of Zhejiang University

Yanbian University

Yanbian University of Science and Technology

Kun Zhu is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in medicine, oncology, and tumor biology.

ORCID

Top concepts

Publications per year

2005–2024

46

Publications

46

Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer

Dawei Yuan, Kang Li, Kun Zhu et al. · Cancer Biology & Therapy · 2015 · 74 citations · Full text

, , +13

PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer

Liyan Chen, Tiefeng Jin, Kun Zhu et al. · Oncotarget · 2017 · 74 citations · Full text

, , +14

A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China

Jianpeng Cai, Ke Lin, Haocheng Zhang et al. · Emerging Microbes & Infections · 2023 · 71 citations · Full text

32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect

Dinesh Chandra, Benson Chellakkan Selvanesan, Ziqiang Yuan et al. · Oncotarget · 2017 · 66 citations · Full text

Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK/STAT signalling pathway.

Kang Li, Dawei Yuan, Rong Yan et al. · PubMed · 2019 · 63 citations

1–5 of 46